| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.004 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.49 | 0.006 |